Naltrexone may lessen chronic pain
Low doses of the opioid antagonist naltrexone may relieve pain associated with fibromyalgia compared with placebo by targeting the immune pathway of pain, researchers said.
Low doses of the opioid antagonist naltrexone may relieve pain associated with fibromyalgia compared with placebo by targeting the immune pathway of pain, researchers said.
Patients with low back pain who don’t respond robustly to intra-articular steroid injections may still be candidates for treatment with radiofrequency ablation (RFA), researchers said here.
Groundbreaking study controls for smoking during pregnancy and antisocial parents. Children who are exposed to second-hand smoke in early childhood are more likely to grow up to physically… read more.
Gabapentin treatment helped more than half of patients achieve relief from postherpetic neuralgia pain (PHN) in a “real-world clinical practice,” researchers said here.
The use of a smartphone application significantly improves patients’ preparation for a colonoscopy, according to new research. The preparation process, which begins days in advance of the procedure,… read more.
In fibromyalgia patients undergoing knee or hip replacement surgery, low-dose, intraoperative ketamine appeared to reduce the need for post-surgical opioid therapy, researchers said.
Considered the “silent killer,” high blood pressure affects approximately one billion people worldwide. Among the findings from the Annual Scientific Meeting of the American Society of Hypertension (ASH)… read more.
The risk of hospitalisation or death from heart disease is 32% lower in vegetarians than people who eat meat and fish, according to a new study from the… read more.
The pain-relieving efficacy of the buprenorphine transdermal medication system didn’t seem to be altered by a patient’s body mass, researchers said.
Young women tend to be less healthy and have a poorer quality of life than similar-aged men before suffering a heart attack, according to research.
Most currently available osteoporosis drugs like denosumab are antiresorptive: they curb bone loss by blocking the action of cells that break down bone (osteoclasts) during the normal process… read more.
Positive findings differ from previous studies on hysterectomy, heart disease risk. Having a hysterectomy with or without ovary removal in mid-life does not increase a woman’s risk of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.